ASIA Records is proud to officially recognise Revery International Group Berhad (REVERY) for achieving the milestone:
First Educational Collaboration to Introduce a Clinically-Deployed AI Coronary Angiography Analysis System to Bachelor-Level Cardiovascular Technology Students (Medipixel MPXA, South Korea; inaugural presentation by Prof. Yongcheol Kim at IJN University College, Kuala Lumpur, 20th July 2026; 50 BCVT students)
This recognition celebrates REVERY’s commitment to advancing cardiovascular education by connecting academic institutions, healthcare organisations, medical technology providers, and international clinical experts.
Through this educational collaboration, 50 Bachelor of Cardiovascular Technology (BCVT) students were introduced to Medipixel MPXA, a clinically deployed artificial intelligence system for coronary angiography analysis developed in South Korea.
The initiative provided students with direct exposure to the growing role of artificial intelligence in interventional cardiology, while supporting the development of future-ready cardiovascular professionals equipped to understand emerging clinical technologies.
Advancing Cardiovascular Education Through International Collaboration
As healthcare continues to adopt digital technologies, artificial intelligence is becoming increasingly relevant to cardiovascular diagnosis, procedural assessment, and clinical decision-making.
Recognising the importance of preparing students for this changing healthcare environment, Revery International Group Berhad, through Revery Laboratory Sdn. Bhd., supported an educational programme at IJN University College, Kuala Lumpur, focused on the application of AI in coronary intervention.
The programme brought together expertise from higher education, clinical practice, medical innovation, and international cardiovascular medicine, creating a platform for students to learn how AI-based systems may complement the work of healthcare professionals.
By introducing bachelor-level students to a technology already deployed within clinical settings, the collaboration helped bridge the gap between academic learning and practical healthcare applications.
Introducing Medipixel MPXA to Future Cardiovascular Professionals
The educational session featured Medipixel MPXA, an AI-powered coronary angiography analysis system originating from South Korea.
The programme was conducted under the topic:
“How Can AI Change My Daily Practice During PCI? – Focus on AI-QCA and Beyond”
The inaugural presentation was delivered by Prof. Kim Yong Cheol, a world-renowned expert in Percutaneous Coronary Intervention (PCI) from the Cardiovascular Center at Yongin Severance Hospital and Yonsei University College of Medicine, South Korea.
During the session, students were introduced to the role of artificial intelligence in coronary angiography analysis and its potential application within PCI-related clinical workflows.
The educational programme also included a question-and-answer session, giving students the opportunity to engage directly with an internationally recognised specialist and gain further insight into the evolving relationship between cardiovascular medicine and AI-assisted technology.
Preparing Students for the Future of Digital Healthcare
The collaboration reflects the growing importance of incorporating relevant technological exposure into healthcare education.
For students pursuing a Bachelor of Cardiovascular Technology, understanding how artificial intelligence may be used within clinical environments can support their preparation for future roles in hospitals, cardiac centres, diagnostic services, and interventional cardiovascular care.
The programme also demonstrated the value of collaboration between educational institutions, medical specialists, healthcare organisations, and technology partners in developing learning opportunities that extend beyond conventional classroom instruction.
By providing access to international expertise and clinically relevant innovation, the initiative supported a broader understanding of how digital health technologies are contributing to the continued advancement of cardiovascular care.
A Milestone Moment of Recognition
The ASIA Records certificate was officially presented on 20 July 2026 during the educational programme held at IJN University College, Kuala Lumpur.
The recognition was received by:
Prof. Emerita Dr. Durrishah Idrus
Vice Chancellor and Chief Executive, IJN University College
Prof. Kim Yong Cheol
World-renowned expert in Percutaneous Coronary Intervention, Cardiovascular Center at Yongin Severance Hospital and Yonsei University College of Medicine, South Korea
Nick Chan
Executive Director, Revery Laboratory Sdn. Bhd.
The presentation was witnessed by YBhg. Dato’ Dr. Mohd Azman bin Yacob, Deputy Director-General of Health (Medical), Ministry of Health Malaysia, reflecting the importance of strengthening collaboration between healthcare institutions, academia, and industry in advancing digital healthcare education.
Voices of Leadership
Reflecting on the recognition, Nick Chan, Executive Director of Revery Laboratory Sdn. Bhd., shared:
“At Revery Laboratory, we believe that innovation creates the greatest impact when it is shared through education. Introducing Medipixel MPXA to Bachelor of Cardiovascular Technology students is not simply about demonstrating an advanced AI solution. It is about giving future healthcare professionals an early understanding of how technology is transforming cardiovascular care and clinical decision-making.
This collaboration represents what can be achieved when industry, academia, healthcare institutions, and international experts work together with a common purpose. We are honoured that ASIA Records has recognised this milestone, and we remain committed to introducing meaningful innovations and educational opportunities that contribute to the advancement of healthcare across Malaysia and the wider Asian region.”
The collaboration reflects REVERY’s commitment to supporting healthcare innovation through education, strategic partnerships, and international knowledge exchange.
By connecting global medical technologies with local institutions and future healthcare professionals, the company continues to contribute to a stronger ecosystem for digital health and cardiovascular excellence across Asia.
Strengthening AI Education in Cardiovascular Care
The introduction of Medipixel MPXA to bachelor-level cardiovascular technology students represents a meaningful step in expanding awareness of artificial intelligence within healthcare education.
As digital technologies continue to influence clinical practice, students benefit from early exposure to the systems, concepts, and applications they may encounter during their future careers.
This initiative also demonstrates how educational collaboration can create practical learning opportunities by bringing together academic leadership, clinical expertise, international specialists, and medical technology organisations.
Through such partnerships, institutions can strengthen the relevance of healthcare education while helping students better understand the technological developments shaping cardiovascular medicine across Asia.
About Revery International Group Berhad
Revery International Group Berhad (REVERY) is committed to supporting healthcare advancement through medical technology, education, professional collaboration, and strategic partnerships.
Through Revery Laboratory Sdn. Bhd., the group works with healthcare institutions, universities, medical professionals, and international technology partners to introduce relevant medical solutions and educational initiatives.
By supporting knowledge exchange and access to emerging healthcare technologies, REVERY continues to contribute to the development of medical education, digital health awareness, and professional capabilities across Malaysia and the wider Asian region.
